The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers

Background and objective Postcardiotomy cardiogenic shock (PCS) is one of the most critical conditions observed in cardiac surgery. Recently, the early initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been recommended for PCS patients to ensure end-organ perfusion, especially in high-volume centers. In this study, we investigated the effectiveness of earlier initiation of VA-ECMO for PCS in low-volume centers. Methods We retrospectively assessed patients admitted in two of our related facilities from April 2014 to March 2019. The patients who underwent VA-ECMO during peri- or post-cardiac surgery (within 48 hours) were included. We divided the patients into two groups according to the timing of VA-ECMO initiation. In the early initiation of VA-ECMO group, the “early ECMO group,” VA-ECMO was initiated when patients needed high-dose inotropic support with high-dose catecholamines, such as epinephrine, without waiting for PCS recovery. In the late initiation of VA-ECMO group, the “late ECMO group,” VA-ECMO was delayed until PCS was not controlled with high-dose catecholamines, with the intent of avoiding severe bleeding complications. Results A total of 30 patients were included in the analysis (early ECMO group/late ECMO group: 19/11 patients). Thirty-day mortality in the entire cohort was 60% (n=18), and there was no significant difference between the two groups (early ECMO group/late ECMO group: 64%/55%, p=0.712). Thirteen and six patients died without being weaned off in the early ECMO (43%) and late ECMO groups (55%), respectively; there was no significant difference between the two groups (p=0.696). The median duration of ECMO support was five days (IQR: 1.5-6.5). Conclusions The early initiation of ECMO did not contribute to patients’ 30-day outcomes in low-volume centers. To improve outcomes of ECMO therapy in patients with PCS, centralization of low-volume centers may be required.

[1]  Y. Naka,et al.  Early venoarterial extracorporeal membrane oxygenation improves outcomes in post-cardiotomy shock , 2020, Journal of Artificial Organs.

[2]  A. Lichtenberg,et al.  Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenation. , 2020, The Journal of thoracic and cardiovascular surgery.

[3]  F. Biancari,et al.  Peripheral versus central extracorporeal membrane oxygenation for postcardiotomy shock: Multicenter registry, systematic review, and meta-analysis. , 2019, The Journal of thoracic and cardiovascular surgery.

[4]  Y. Naka,et al.  Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation. , 2019, Journal of thoracic disease.

[5]  J. van der Linden,et al.  Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality , 2018, The Journal of thoracic and cardiovascular surgery.

[6]  N. Al-Attar,et al.  Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis , 2017, Journal of Cardiothoracic Surgery.

[7]  D. Brodie,et al.  Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. , 2014, Journal of the American College of Cardiology.

[8]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[9]  R. Bellomo,et al.  An extracorporeal membrane oxygenation-based approach to cardiogenic shock in an older population. , 2001, The Annals of thoracic surgery.

[10]  P. McCarthy,et al.  Complications of extracorporeal life support systems using heparin-bound surfaces. The risk of intracardiac clot formation. , 1995, The Journal of thoracic and cardiovascular surgery.

[11]  L. Golding Postcardiotomy mechanical support. , 1991, Seminars in thoracic and cardiovascular surgery.